[1] WANG C C, CHIANG Y M, KUO P L, et al. Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway[J]. Clin Exp Pharmacol Physiol,2008,35(11):1301-1308. DOI:10.1111/j.1440-1681.2008.05007.x. [2] GUO A, LIU A, TENG X. The pathology of urinary bladder lesions with an inverted growth pattern[J]. Chin J Cancer Res, 2016, 28(1): 107-121. DOI:10.3978/j.issn.1000-9604.2016.02.01. [3] ZHANG A, XU M, MO Y Y. Role of the lnc-p53 regulatory network in cancer[J]. J Mol Cell Biol, 2014, 6(3):181-191. DOI:10.1093/jmcb/mju013. [4] LI X, WU Z, FU X, et al. LncRNAa: insights into their function and mechanics in underlying disorders[J]. Mutat Res Rev Mutat Res,2014,762:1-21. DOI:10.1016/j.mrrev.2014.04.002. [5] SUN M, KRAUS W L. From discovery to function: The expanding roles of long noncoding RNAs in physiology and disease[J]. Endocr Rev, 2015,36(1):25-64. DOI:10.1210/er.2014-1034. [6] YANG Y, GUO J X, SHAO Z Q, et al. Matrine inhibits bladder cancer cell growth and invasion in vitro through PI3K/Akt signaling pathway: An experimental study[J]. Asian Pac J Trop Med,2017,10(5):515-519. [7] ROBBINS H L, HAGUE A. The PI3K/Akt pathway in tumors of endocrine tissues[J]. Front Endocrinol, 2015,6:188. DOI:10.3389/fendo.2015.00188. [8] WANG L X, FU D, QIU Y, et al. Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma[J]. Cancer Lett, 2014,349(1):77-86. [9] HEERY R, FINN S P, CUFFE S, et al. Long Non-Coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells[J]. Cancers, 2017, 9(4): 38. DOI:10.3390/cancers9040038. [10] KEAY K S, BIRDER L A, CHAI T C. Evidence for bladder urothelial pathophysiology in functional bladder disorders[J]. Biomed Res Int, 2014,2014: 865463. DOI:10.1155/2014/865463. |